Zensar Technologies Ltd Q3 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/ydbs0f7i5zul6tkwrv5kv5tw.pdf

Key Takeaways


Demand Environment

Tandon: "if we continue to see significant stress in Hi-Tech, I don't know whether the growth will be enough to offset or if Hi-Tech remains flattish or grows slightly then I see us growing significantly."

Vertical Performance

VerticalTrendCommentary
BFSI▲ StrongGrew 12.6% YoY; company doing well in UK, Europe and South Africa.
Manufacturing & Consumer Services▲ GrowthGrew 5.5% YoY; things are looking up.
Hi-Tech▼ WeakIndustry-wide stress; lower revenues from some large customers; furloughs continue into early Q4.
Healthcare▼ DeclinedLarge YoY degrowth on a small base from project completions and furloughs; peers in the payer segment benefit from Q3 open enrollment.
Life Sciences▼ SoftDegrowth largely due to furloughs, with some project completions also contributing.

Service Lines & Operational Efficiency


Margins

Margin walk (QoQ)Impact
Furloughs and utilization–200 bps
Exchange impact–10 bps
Operational efficiency, higher leave utilization, reduced discretionary spends+140 bps
SG&A increase (incl. reversal of 160 bps prior-quarter benefit on lower bonus payout)–70 bps
Net gross margin change–70 bps

AI, Strategy & Positioning

Tandon: "We are perhaps the only company of our size which can do these all three things together and in sync with each other."

Guidance & Commitments

CommitmentSpecificsTimeline
Adjusted EBITDA margin band14% to 16% sustainable rangeOngoing
Furlough reversalExpected outside Hi-Tech; Hi-Tech furloughs continue into early Q4Q4 FY24
Macro environmentNo material change expectedNext two quarters
Healthcare vertical contributionHope is that Healthcare will contribute disproportionately; vertical is 2-3 months old, hiring and M&A underwayNo date (early stage)
Hi-Tech stabilization"The jury is still out there"; if flattish, company grows significantly; if significant stress continues, offset is uncertainNo date (conditional)

Key Metrics

MetricQ3 FY24
Revenue$144.7 million, decline of 3.2% sequentially in constant currency and 3.7% in reported terms
Services revenue$144.5 million, YoY growth of 1.8% in reported terms and 1.3% in constant currency
Gross margin31.1%, a drop of 70 bps QoQ; furlough and utilization impact of 200 bps partially offset by operational efficiencies of 140 bps
EBITDA margin17.2%, up 20 bps against last quarter adjusted EBITDA margins
Adjusted EBITDA margin (YTD)17.3%, well above guided range of mid-teens
Profit after tax growth700 bps YoY increase
Effective tax rate23.8%
Order book$167.5 million, compared to $194.8 million in Q2 FY24 and $37 million more than same quarter last year
Cash and cash equivalents$248.3 million, compared to $227.1 million in Q2 FY24, with addition of $21.3 million in the quarter
DSO75 days, 4 days lower than previous quarter
LTM voluntary attrition12.0%, improved from 13.1% last quarter
UtilizationOver 80%, compared to 77.6% in Q3 last year; 310 bps higher YoY
Gross employee addition627 employees in the quarter
BFSI revenue growth12.6% YoY in constant currency
Manufacturing and Consumer Services revenue growth5.5% YoY in constant currency
Hi-Tech revenue growth-9.6% YoY in constant currency
Healthcare revenue growth-14.3% YoY in constant currency
Advanced Engineering Services revenue growth3.0% QoQ in reported terms
Application Services and Enterprise Applications Services revenue growth-8.0% QoQ, primarily on account of furloughs
Share of revenues from Advanced Engineering, Data Engineering and Analytics, Experience Services and Foundation Services54.2%, up from 52.2% in Q2 FY24
Outstanding hedges$313.7 million, against $289.1 million in previous quarter
Interim dividendRs. 2 per share, 100% of face value